Treatment of cutaneous lupus erythematosus.
The mainstays of treatment of cutaneous lupus erythematosus (LE) are topical and intralesional steroids, sunscreen, and the antimalarials. However, the practitioner is often faced with the challenge of cutaneous disease unresponsive to these conventional measures. We present our approach to the management of cutaneous LE and review the literature regarding therapy of refractory disease.
Rothe
M J
MJ
Division of Dermatology, University of Connecticut Health Center, Farmington.
Kerdel
F A
FA
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000962:Antimalarials / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D004351:Drug Resistance; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D008178:Lupus Erythematosus, Cutaneous / Q000188:drug therapy* / Q000601:surgery; D010778:Photochemotherapy; D012176:Retinoids / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000962:Antimalarials; D007166:Immunosuppressive Agents; D016898:Interferon-alpha; D012176:Retinoids; D014810:Vitamin E; D003622:Dapsone